Expression of allograft inflammatory factor-1 in inflammatory skin disorders

21Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Allograft inflammatory factor-1 (AIF-1) is an evolutionary conserved, inflammatory protein produced by activated macrophages during chronic transplant rejection and in inflammatory brain lesions. Since T-cell-mediated inflammation is common to various dermatoses and nothing is known about AIF-1 in skin, we studied its protein expression at the tissue level and regulation in monocytic cell lines by various agents. Using immunohistochemistry, we found that AIF-1 is expressed at low levels in normal skin, but is highly upregulated in various inflammatory skin disorders, such as psoriasis, lichen planus, graft-versus-host disease and mycosis fungoides. The main cell types expressing AIF-1 in affected skin are macrophages and Langerhans' cells. We also show by real-time PCR that AIF-1 mRNA levels in monocytic THP-1 and U937 cell lines are significantly upregulated by retinoic acid as well as a number of cytokines. We conclude that AIF-1 may mediate survival and pro-inflammatory properties of macrophages in skin diseases. © 2007 Acta Dermato-Venereologica.

Cite

CITATION STYLE

APA

Orsmark, C., Skoog, T., Jeskanen, L., Kere, J., & Saarialho-Kere, U. (2007). Expression of allograft inflammatory factor-1 in inflammatory skin disorders. Acta Dermato-Venereologica, 87(3), 223–227. https://doi.org/10.2340/00015555-0225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free